Mitochondria are essential for cell survival, repair, and adaptation. Not only do they generate most of the energy needed ...
Researchers uncover how cells internalize transplanted mitochondria, paving the way for new energy-restoring therapies for Parkinson’s and Alzheimer’s.
A novel, rapid and non‑destructive method was developed to provide real-time insights into iron flux in mesenchymal stromal cells (MSCs) using a micromagnetic resonance relaxometry (µMRR) deviceThe ...
The ORR was 70% in patients treated with remestemcel-L, with 30% having a complete response and 41% having a partial response. The Food and Drug Administration (FDA) has approved Ryoncil ® ...
The US Food and Drug Administration (FDA) has approved remestemcel-L (Ryoncil, Mesoblast Ltd), an allogeneic bone marrow‒derived mesenchymal stromal cell (MSC) therapy for steroid-refractory acute ...
Lancet Phase 1 study finds in-womb stem cell therapy feasible and safe in spina bifida, supporting expansion to a larger clinical trial.
Mitochondrial transplantation is an emerging technique aimed at restoring cellular energy production in diseases marked by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results